Director - Queensland Centre for Gynaecological Cancer (QCGC)

Dr Crandon is a surgical oncologist specialising in the management of women with genital tract cancer, i.e., cancers of the ovary, uterus, tube, cervix, vaginal and vulva as well as gestational trophoblastic disease. He is the Director of the Queensland Centre for Gynaecological Cancer (QCGC) established in 1994 and is currently an Adjunct Professor at Queensland University of Technology (QUT).  Dr Crandon held the Chair (Professor) of Gynaecological Cancer at the University of Queensland from 1993 to 2004. Prior to coming to Queensland he was Chair of Gynaecological Cancer at Westmead Hospital in western Sydney.

His particular interests are in the surgical management of cancer, with a special interest in the surgical treatment of ovarian, tubal and primary peritoneal cancer.   Over the last 25 years there have been substantial changes in chemotherapy agents with some beneficial improvement in results; however, there has been little change in the surgery of these disorders over the same period of time.   Recently, he has been exploring the use of radical cytoreductive surgery or peritonectomy along with Hyperthermic Intraoperative Intraperitoneal Chemotherapy (HIPC) both of which promise to significantly improve the survival of patients.

Dr Crandon graduated from the University of Sydney and worked at the Royal Prince Alfred Hospital, Sydney, before travelling to England where he undertook five years of postgraduate study.  In Leeds, Yorkshire, he completed his specialist training (MRCOG), trained in surgical oncology at the Leeds General Infirmary largely with Prof. John Goligher, and completed his PhD at Leeds University before returning to Sydney at Westmead Hospital in 1980.